News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

OHSU earns Deals of Distinction™ Award for the Industry-University-Government Interface Sector

LES to Honor 15th Annual Deals of Distinction™ Award Winners at its Phoenix Annual Meeting, October 21-23

LES Members to Be Recognized for Outstanding Achievements in the Field of Licensing Business Deals at LES 2019 Annual Meeting in Phoenix, October 21

RESTON, VA. – Sept. 30, 2019 — The Licensing Executives Society (U.S.A and Canada), Inc. (LES) today announced the recipients of its Deals of Distinction™ Awards in four industry sectors. The annual program, now in its fifteenth year, recognizes […]

October 14, 2019 |

Policy Points: Oregon Bio advocates for patient-centered care, repealing the medical device excise tax, and inviting members to review FDA draft guidance for the Safer Technologies Program

Oregon Bio’s public advocacy work on behalf of its members has turned its attention to federal congressional actions. OR Bio members are invited to reach out to their Member of Congress* to learn more about these important, current issues: 

Could patient-centered care be outlawed by House Resolution 3?  HR3 includes the Lower Drug Costs Now Act 2019, which aims to create reference pricing structures, introduces price control mechanisms from foreign countries, and imposes extreme penalties on U.S. innovation, researchers and drug developers. These penalties are said to include an […]

Voice of Industry: Lisa Hale, CEO of Grace Bio-Labs, Part 1

Oregon Bio recently caught up with Lisa Hale, CEO of Grace Bio-Labs, headquartered in Bend, Oregon. Started three decades ago, the company has grown as a globally recognized developer and manufacturer of tools for life science research, working to understand how protein and single-cell interactions are relevant in cancer detection. 

As a voice of industry, we wanted to hear Grace Bio-Labs perspective: 

OR Bio: How does Grace Bio-Labs fit into Oregon’s biotech and life science ecosystem? The region? 

LH:  Typically when you hear the term “biotech” you think of the Bay Area, Seattle, […]

WHAT 8 OREGON BIOSCIENCE COMPANIES AND 8 LIFE SCIENCE RESEARCHERS HAVE IN COMMON

Emerging bio companies and researchers are selected to present, showcasing leading thought in bioscience innovation at Oregon Bio 2019: Innovating and Scaling for our Region’s Growth – the conference created for investors, start-up entrepreneurs, executives, researchers and policymakers, happening Oct. 29 in Portland.  #OregonBio2019

FOR IMMEDIATE RELEASE – October 9, 2019

CONTACT: Dianne Danowski Smith, (503) 201-7019, @OregonBio

(Portland, Ore.)  – The Oregon Bioscience Association announced the eight regional bioscience companies, representing the device, diagnostic, digital health and therapeutics sectors, selected […]

October 9, 2019 |

Corporate Activity Tax Town Hall Meetings: Your Thoughts Wanted

The Oregon Department of Revenue invites you to take part in a discussion of the administrative rules for the state’s new Corporate Activity Tax. Traveling across Oregon, rule writers will sit down in a series of meetings over the next three weeks to hear the concerns, questions, and suggestions of those affected by the rules.

The full meeting schedule includes stops in Corvallis, Beaverton, Medford, Grants Pass, Eugene, Bend, Redmond, Hermiston, Boardman, Portland, and Salem. For out of out-of-state business taxpayers […]

September 26, 2019 |

OREGON AND SOUTHWEST WASHINGTON’S LIFE SCIENCE INDUSTRY: POSITIONING FOR GROWTH

Oregon Bio 2019: Innovating and Scaling for our Region’s Growth is the annual conference aimed at investors, start-up entrepreneurs, executives, researchers, policymakers and bio-supply chain sector executives, happening Oct. 29 in Portland.  #OregonBio2019

CONTACT: Dianne Danowski Smith, (503) 201-7019, @OregonBio

(Portland, Ore.)  – In only three minutes, rising-star researchers from high schoolers to post- doctoral investigators will highlight their research to more than 150 bioscience professionals, industry experts, enthusiasts, and judges at Oregon Bio 2019: Innovating and Scaling for […]

Request for Proposals: Cross-Gorge Incumbent Worker Training Grant

Now Accepting Proposals

EC Works and SCWDC are seeking proposals from employers, who straddle our shared labor shed and are looking for resources to support training for their current workforce. Qualified employers will have employees who live on both sides of the Columbia River (Washington and Oregon) and whose physical business location is situated in any one of the counties within the cross Gorge labor shed of: Hood River, Wasco, Sherman, Gilliam, Skamania and Klickitat. EC Works and SCWDC will fund […]

September 5, 2019 |

Voice of Industry: Q&A with RevMedx’s President and CEO

Andrew Barofsky, J.D., MBA, launched and leads RevMedx, a growing biotech firm in North Wilsonville focused on trauma care and hemorrhage control solutions. RevMedx develops products called X-STATâ, Parabelt, XGauze, Airwrap, and others. “Saving lives is our mission” stands as their business motto.

Barofsky is the outgoing Board Chair of the Oregon Bioscience Incubator at the Oregon Translational Research and Development Institute; he has also served on the Board of Oregon Bio. We reached out to him to talk about RevMedx’s […]

August 30, 2019 |

Oregon Business Plan: Executive survey to drive economic policy

Dear Colleague,

You are invited to complete a  5-10 minute survey sponsored by the Oregon Business Plan.

What is the Oregon Business Plan

As you may know, the Oregon Business Plan (OBP) is both a partnership of Oregon’s major business organizations and a strategy to grow jobs, raise incomes and reduce poverty by supporting policies for economic growth and well-being.

Why your perspective is so important to hear

As part of an effort to update the Oregon Business Plan’s strategy to grow the economy, […]

Oregon Bio View from Academia: Jackie Wirz, Ph.D. Part 2

A few weeks ago, we introduced a new occasional focus section called the View From Academia. We will spotlight the many leading professionals who work in our research universities and in our R&D community.  Today, we’re finishing our talk with Jackie Wirz, Ph.D., Assistant Dean for Graduate Studies and Director of Career and Professional Development at OHSU, where her job is to help students thrive and find success as new professionals. Here’s Part 2 of our discussion.

Q: How does your […]

August 16, 2019 |

Cancer therapies that harness the immune system don't work for all patients. Verseau Therapeutics aims to bring cancer immunotherapy to more people by targeting a type of immune cell present in t [...]

Sen. Elizabeth Warren (D-Mass.), a leading Democratic presidential candidate, said Sunday she will soon be releasing a plan outlining how she will finance her "Medicare for All" health care [...]

A growing number of Senate Democrats say Sen. Elizabeth Warren (D-Mass.) should be more explicit about how she plans to pay for her "Medicare for All" plan.They say the transparency will be [...]

Google snagged Karen DeSalvo, a former health official in the Obama administration, to become its first chief health officer. Her appointment is just the latest in a string of hires that deepen the te [...]

Welcome to Friday's Overnight Health Care.The Ebola outbreak may finally be slowing, but so is funding. Another House progressive Democrat is calling for changes to drug pricing legislation, and [...]

Johnson & Johnson's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos in the company's baby powder, triggering a recall. J&J only pulled one [...]

Spring Bank Pharmaceuticals' hepatitis B drug, given in tandem with Gilead's Vemlidy, tamped down on chronic disease in more than one-fifth of patients in a phase 2 study--a result that Jeff [...]

Pfizer's tafamidis franchise has been on a road paved with blockbuster hopes since its FDA nod in May. Now, one group of analysts says the drug's early uptake has been faster than expected-- [...]